Home/Pipeline/MariTide (AMG 133)

MariTide (AMG 133)

Obesity / Weight Management

Phase 2Active

Key Facts

Indication
Obesity / Weight Management
Phase
Phase 2
Status
Active
Company

About Amgen

Amgen is a foundational pillar of the global biotechnology industry, with a mission to serve patients by transforming the promise of science into therapies that restore health or save lives. The company has achieved a dominant market position through its deep expertise in biologics manufacturing, a diversified portfolio of blockbuster medicines, and a robust pipeline targeting major therapeutic areas including cardiovascular disease, obesity, oncology, and inflammation. Its strategy is centered on leveraging advanced technologies like AI and human genetics to accelerate innovation, expand its manufacturing footprint, and deliver long-term growth.

View full company profile

Other Obesity / Weight Management Drugs

DrugCompanyPhase
GLP-1 Analog Transdermal PatchQuiaPEG PharmaceuticalsPreclinical
AJN003 PlatformAltrixBioPre-clinical